Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

PHILADELPHIA and LONDON, February 28 /PRNewswire/ --

- Thomson Research Award Ceremony Celebrates the Best in Australian Research During an Event to be Held at the National Press Club on 2 April

Thomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC) and leading provider of information solutions to the worldwide research and business communities, today announced it will honor Australia's preeminent researchers at the National Press Club in Canberra on Wednesday, 2 April, 2008.

TOKYO, February 28 /PRNewswire/ --

Kyowa Hakko Kogyo Co., Ltd. President: Dr. Yuzuru Matsuda announced that Kyowa Pharmaceutical, Inc. (New Jersey, United States), its wholly owned U.S. subsidiary, received on February 25, 2008 a Not approvable letter from the U.S. Food and Drug Administration (FDA) for istradefylline (KW-6002), its investigational drug for the treatment of Parkinson's disease.

In the not approvable letter FDA expressed concern if the efficacy findings support clinical utility of istradefylline (KW-6002). The FDA requested an overall summary of nonclinical mineralization findings. Additionally, the FDA asked for clinical pharmacology follow-up information as a Phase 4 commitment.

ASHBY DE LA ZOUCH, England, February 28 /PRNewswire/ --

Siemens today underlined its commitment to creating greener railways, with the launch of a major initiative at today's RAIL 2008 conference.

RALEIGH, North Carolina, February 27 /PRNewswire/ --

DARA BioSciences(TM) (Nasdaq: DARA) announced today the appointment of Haywood D. Cochrane, Jr. to the Board of Directors. Mr. Cochrane was appointed to fill a Board vacancy and will serve on the Company's Audit and Compensation Committees. The appointment was effective February 21, 2008.

In making the announcement DARA's Board Chairman, Richard Franco, Sr., commented, "We are pleased that Haywood has joined us as a Director. His vast knowledge and successful experience in the healthcare industry will further strengthen DARA's already skilled Board."

LOS ANGELES, February 27 /PRNewswire/ --

- Managed Hosting Customers to Benefit from Reliability, Performance of Next-Generation Technology

Verizon Business managed hosting customers will be among the first to benefit from the powerful new functionality of Microsoft Windows Server 2008, the next-generation server operating system launched worldwide by Microsoft Wednesday (Feb. 27).

As a member of Microsoft's early adopter initiative, known as the Rapid Deployment Program (RDP), Verizon Business has gained critical expertise that will enable it to offer Windows Server 2008 as a high-end managed hosting solution to U.S. customers this spring, with rollout to European and Asia-Pacific customers by late summer.

PARIS, February 27 /PRNewswire/ --

- New Optical Transmission With Capacity x Distance Product Record at 41.8 Petabit/s.km, and Three New Photonic Integrated Circuits

Alcatel-Lucent (Euronext and NYSE: ALU) today announced, in four post deadline papers accepted at the OFC/NFOEC conference in San Diego, California, new optical networking milestones, including a new optical transmission record and three novel new photonic integrated circuits.